Home » Companies
Contrasting Hypha Labs (OTCMKTS:DIGP) & Suncast Solar Energy (OTCMKTS:SUNC)
Hypha Labs (OTCMKTS:DIGP – Get Free Report) and Suncast Solar Energy (OTCMKTS:SUNC – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of... More of this article »
LyondellBasell Industries (NYSE:LYB) Given New $70.00 Price Target at Jefferies Financial Group
LyondellBasell Industries (NYSE:LYB – Free Report) had its target price upped by Jefferies Financial Group from $51.00 to $70.00 in a research report report published on Tuesday,Benzinga reports. They currently have a hold rating... More of this article »
BETA Technologies (NYSE:BETA) Price Target Cut to $29.00 by Analysts at Jefferies Financial Group
BETA Technologies (NYSE:BETA – Free Report) had its price objective trimmed by Jefferies Financial Group from $30.00 to $29.00 in a research report report published on Tuesday,Benzinga reports. The brokerage currently has a buy... More of this article »
Federal Signal (NYSE:FSS) Upgraded to Overweight at KeyCorp
KeyCorp upgraded shares of Federal Signal (NYSE:FSS – Free Report) from a sector weight rating to an overweight rating in a research report sent to investors on Tuesday morning, MarketBeat.com reports. The brokerage currently... More of this article »
BETA Technologies’ (BETA) Buy Rating Reaffirmed at BTIG Research
BTIG Research reissued their buy rating on shares of BETA Technologies (NYSE:BETA – Free Report) in a report released on Tuesday morning,Benzinga reports. The firm currently has a $40.00 target price on the stock. Several other... More of this article »
Rep. Julia Letlow Sells Off Shares of Micron Technology, Inc. (NASDAQ:MU)
Representative Julia Letlow (Republican-Louisiana) recently sold shares of Micron Technology, Inc. (NASDAQ:MU). In a filing disclosed on January 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Micron... More of this article »
BETA Technologies (NYSE:BETA) Price Target Lowered to $33.00 at Morgan Stanley
BETA Technologies (NYSE:BETA – Free Report) had its price target cut by Morgan Stanley from $34.00 to $33.00 in a research report report published on Tuesday,Benzinga reports. They currently have an overweight rating on the stock. A... More of this article »
American Century Companies Inc. Has $17.02 Million Stake in PT Telekomunikasi Indonesia, Tbk $TLK
American Century Companies Inc. raised its position in shares of PT Telekomunikasi Indonesia, Tbk (NYSE:TLK – Free Report) by 11.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange... More of this article »
Akebia Therapeutics Details Vafseo Commercial Push, TIW Dosing Plans and Kidney Pipeline at Leerink Conference
Akebia Therapeutics (NASDAQ:AKBA) executives outlined the company’s near- and mid-term priorities at the Leerink Partners Global Healthcare Conference, emphasizing the commercialization of its anemia drug Vafseo, continued investment... More of this article »
Acadia Healthcare CFO Details 2026 Focus: Bed Ramp-Ups, Medicaid Headwinds, and Malpractice Costs
Acadia Healthcare (NASDAQ:ACHC) Chief Financial Officer Todd Young, who joined the company about four months ago, outlined management’s focus areas for 2026 during a conference discussion that touched on facility ramp-ups, organizational... More of this article »
National Grid Transco, PLC $NGG Shares Bought by American Century Companies Inc.
American Century Companies Inc. grew its position in National Grid Transco, PLC (NYSE:NGG – Free Report) by 18.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission... More of this article »
American Century Companies Inc. Has $17.46 Million Stock Holdings in Cavco Industries, Inc. $CVCO
American Century Companies Inc. increased its stake in Cavco Industries, Inc. (NASDAQ:CVCO – Free Report) by 282.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange... More of this article »
Cenovus Energy Inc $CVE Shares Bought by American Century Companies Inc.
American Century Companies Inc. raised its stake in Cenovus Energy Inc (NYSE:CVE – Free Report) (TSE:CVE) by 25.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange... More of this article »
NewAmsterdam Pharma Company N.V. $NAMS Shares Bought by American Century Companies Inc.
American Century Companies Inc. lifted its position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS – Free Report) by 17.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned... More of this article »
Genius Group H2 Earnings Call Highlights
Genius Group (NYSEAMERICAN:GNS) used its investor call to discuss full-year 2025 results and outline its operating plan and targets for 2026, with founder and CEO Roger James Hamilton and CFO Gaurav Dama highlighting a restructuring-driven... More of this article »
Ardelyx Touts IBSRELA’s 73% Growth, Reaffirms $1B 2029 Goal and Details CIC Phase III Plan
Ardelyx (NASDAQ:ARDX) executives outlined commercial momentum for IBSRELA and XPHOZAH, key investment priorities for 2026, and development plans for a chronic idiopathic constipation (CIC) expansion at a Global Healthcare Conference,... More of this article »
Nu Skin Enterprises, Inc. $NUS Shares Purchased by American Century Companies Inc.
American Century Companies Inc. boosted its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 21.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities... More of this article »
American Century Companies Inc. Has $16.62 Million Stock Holdings in Great Southern Bancorp, Inc. $GSBC
American Century Companies Inc. grew its holdings in Great Southern Bancorp, Inc. (NASDAQ:GSBC – Free Report) by 9.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission.... More of this article »
Repay Q4 Earnings Call Highlights
Repay (NASDAQ:RPAY) executives highlighted an acceleration in normalized growth and continued profitability as the company closed out 2025, while outlining a 2026 outlook that incorporates both organic initiatives and expected contributions... More of this article »
AdaptHealth Calls 2025 a Transition Year, Builds for 2026 Growth Ahead of Kaiser DME Deal
AdaptHealth (NASDAQ:AHCO) is treating 2025 as a “transition and investment” year focused on operational streamlining and infrastructure buildout, while positioning 2026 as a year geared toward growth, Chief Financial Officer Jason... More of this article »
Constellation Software Q4 Earnings Call Highlights
Constellation Software (TSE:CSU) executives used the company’s 2025 fourth-quarter results call to address investor questions around artificial intelligence, capital allocation, and a newly formalized minority-investment approach... More of this article »
Alumis Teases TYK2 Catalysts at Leerink: Phase III Psoriasis Wins, NDA Plan and Lupus Readout Ahead
Alumis (NASDAQ:ALMS) executives highlighted recent clinical progress for the company’s TYK2 inhibitor programs and previewed multiple upcoming catalysts during remarks at the Leerink Partners Global Healthcare Conference. CEO Martin... More of this article »
Kenmare Resources Warns Mozambique IA Renewal Talks Could Lift Royalties and VAT Working Capital Risk
Kenmare Resources (LON:KMR) used an investor presentation to update shareholders on negotiations with the Government of Mozambique to renew its Implementation Agreement (IA), outlining both the terms the company has offered and recent... More of this article »
Unusual Machines Q4 Earnings Call Highlights
Unusual Machines (NYSEAMERICAN:UMAC) used its fourth-quarter earnings call to outline what management described as a major transition in 2025, shifting from an online retail business toward U.S.-based production of drone components... More of this article »
Aktis Oncology Unveils Miniprotein Radiopharma Platform, Highlights Nectin-4 and B7-H3 Programs
Aktis Oncology (NASDAQ:AKTS) executives outlined the company’s strategy to expand the use of targeted radiopharmaceuticals beyond the limited set of currently approved products, emphasizing a novel “miniprotein” targeting approach,... More of this article »
American Century Companies Inc. Buys 46,881 Shares of TrustCo Bank Corp NY $TRST
American Century Companies Inc. lifted its position in TrustCo Bank Corp NY (NASDAQ:TRST – Free Report) by 10.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
American Century Companies Inc. Increases Position in Constellium SE $CSTM
American Century Companies Inc. increased its holdings in Constellium SE (NYSE:CSTM – Free Report) by 57.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned... More of this article »
American Century Companies Inc. Cuts Holdings in Steel Dynamics, Inc. $STLD
American Century Companies Inc. lessened its stake in Steel Dynamics, Inc. (NASDAQ:STLD – Free Report) by 41.1% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 118,323 shares of the basic... More of this article »
AutoCanada (AOCIF) Expected to Announce Earnings on Wednesday
AutoCanada (OTCMKTS:AOCIF – Get Free Report) is expected to be issuing its results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of $0.3439 per share and revenue of $1.1234... More of this article »
Vail Resorts Q2 Earnings Call Highlights
Vail Resorts (NYSE:MTN) reported fiscal second-quarter 2026 results that management said were heavily pressured by what it described as the most difficult weather environment the company has ever seen in the Rockies. Executives emphasized... More of this article »
American Century Companies Inc. Purchases 24,820 Shares of Avantis Real Estate ETF $AVRE
American Century Companies Inc. boosted its position in Avantis Real Estate ETF (NYSEARCA:AVRE – Free Report) by 7.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission... More of this article »
HelloFresh (HLFFF) to Release Quarterly Earnings on Wednesday
HelloFresh (OTCMKTS:HLFFF – Get Free Report) is expected to be issuing its results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of $1.27 per share and revenue of $1.5769 billion... More of this article »
Stereotaxis Q4 Earnings Call Highlights
Stereotaxis (NYSEAMERICAN:STXS) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight a year of regulatory milestones, a shifting business model toward higher recurring revenue, and near-term... More of this article »
American Century Companies Inc. Lowers Holdings in Towne Bank $TOWN
American Century Companies Inc. reduced its holdings in shares of Towne Bank (NASDAQ:TOWN – Free Report) by 18.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange... More of this article »
American Century Companies Inc. Purchases 1,101,137 Shares of VNET Group, Inc. – Unsponsored ADR $VNET
American Century Companies Inc. increased its holdings in shares of VNET Group, Inc. – Unsponsored ADR (NASDAQ:VNET – Free Report) by 180.3% during the third quarter, according to the company in its most recent 13F filing... More of this article »
Protagonist Therapeutics (PTGX) Projected to Post Quarterly Earnings on Wednesday
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) will likely be issuing its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect Protagonist Therapeutics to post earnings of ($0.5415) per... More of this article »
American Century Companies Inc. Grows Position in Gentherm Inc $THRM
American Century Companies Inc. increased its holdings in Gentherm Inc (NASDAQ:THRM – Free Report) by 36.1% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 513,791 shares... More of this article »
Myomo Q4 Earnings Call Highlights
Myomo (NYSEAMERICAN:MYO) reported fourth-quarter and full-year 2025 results that management said showed progress across its growth, reimbursement, cost, and product development priorities, while also highlighting ongoing headwinds... More of this article »
Alvotech (ALVO) Projected to Post Earnings on Wednesday
Alvotech (NASDAQ:ALVO – Get Free Report) is projected to post its Q4 2025 results after the market closes on Wednesday, March 18th. Analysts expect the company to announce earnings of $0.13 per share and revenue of $162.1950... More of this article »
American Century Companies Inc. Grows Stock Position in First Industrial Realty Trust, Inc. $FR
American Century Companies Inc. increased its holdings in First Industrial Realty Trust, Inc. (NYSE:FR – Free Report) by 609.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 360,223... More of this article »
American Century Companies Inc. Buys 206,778 Shares of Worthington Steel, Inc. $WS
American Century Companies Inc. grew its stake in Worthington Steel, Inc. (NYSE:WS – Free Report) by 51.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission... More of this article »
American Century Companies Inc. Acquires 144,530 Shares of Dr. Reddy’s Laboratories Ltd $RDY
American Century Companies Inc. grew its holdings in Dr. Reddy’s Laboratories Ltd (NYSE:RDY – Free Report) by 13.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional... More of this article »
American Century Companies Inc. Boosts Position in Millrose Properties, Inc. $MRP
American Century Companies Inc. grew its holdings in shares of Millrose Properties, Inc. (NYSE:MRP – Free Report) by 45.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities &... More of this article »
Zevra Therapeutics Q4 Earnings Call Highlights
Zevra Therapeutics (NASDAQ:ZVRA) reported fourth quarter and full-year 2025 results highlighted by growing commercial traction for its Niemann-Pick disease type C (NPC) therapy MIPLYFFA and a shift to profitability, while outlining... More of this article »
Cipher Mining Inc. $CIFR Shares Acquired by American Century Companies Inc.
American Century Companies Inc. lifted its stake in shares of Cipher Mining Inc. (NASDAQ:CIFR – Free Report) by 138.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.... More of this article »
American Century Companies Inc. Grows Position in First Financial Corporation Indiana $THFF
American Century Companies Inc. raised its position in First Financial Corporation Indiana (NASDAQ:THFF – Free Report) by 11.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities... More of this article »
American Century Companies Inc. Trims Stock Position in Fifth Third Bancorp $FITB
American Century Companies Inc. decreased its position in Fifth Third Bancorp (NASDAQ:FITB – Free Report) by 3.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 402,907 shares... More of this article »
Absci Highlights AI Antibody Platform, ABS-201 Hair-Loss Trial Milestones at Leerink Conference
Absci (NASDAQ:ABSI) used a presentation at the Leerink Partners Global Healthcare Conference to outline how the company is applying its internal AI-driven drug design platform to generate “differentiated” antibody assets, while... More of this article »
